About | Free Trial

Last Update

2016-02-28T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong B. Thompson?

Dr. B. Thompson Taylor

Medical Director of the NHLBI-funded PETAL Clinical Coordinating Center

Massachusetts General Hospital

HQ Phone: (617) 726-2000

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Massachusetts General Hospital

55 Fruit Street

Boston, Massachusetts 02114

United States

Company Description

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $800 m ... more

Find other employees at this company (9,175)

Background Information

Employment History

Practicing Intensivist and Educator

Harvard Medical School

Field Applications Specialist

Promega Corporation

Associate Professor

Harvard University

Affiliations

Advisor
Physician Scientific

Clinical Advisory Board Member
BioAegis Therapeutics Inc

Clinical Advisory Board Member
Compendium

Member
The American Physiological Society

Member
American Thoracic Society

Education

MD

University of California

undergraduate degree

Physiology

University of California , Davis

Web References (51 Total References)


Dr. B. Taylor Thompson | Critical Care Canada

www.criticalcarecanada.com [cached]

B. Taylor Thompson

Dr. B. Taylor Thompson
...
Dr. Thompson is a Professor of Medicine at Harvard Medical School and the Medical Director of the NHLBI-funded PETAL Clinical Coordinating Center at the Massachusetts General Hospital. His primary research interests are clinical trials of new therapies for ARDS and sepsis. Dr. Thompson has been a practicing intensivist and educator at MGH and Harvard Medical School for over 30 years..


B. Taylor Thompson, ...

bioaegistherapeutics.com [cached]

B. Taylor Thompson, MD

...
Dr. Thompson is Professor of Medicine at Harvard Medical School and Director of Pulmonary and Critical Care Translational Research at the Massachusetts General Hospital in Boston. He is a clinical trialist and serves as Medical Director of the Clinical Coordinating Center of the National Institute of Health's Prevention and Early Treatment of Acute Lung Injury (PETAL) clinical trials network. In addition to ARDS, Dr. Thompson's clinical and research interests include therapeutic interventions for severe sepsis. He is an internationally recognized clinical trialist and serves on a number of Data and Safety Monitoring Boards for the NIH and the pharmaceutical industry. He has written over 200 peer reviewed articles and book chapters, has participated in the development of clinical trial and educational software, and has served on two Surviving Sepsis Treatment Guideline committees.
Dr. Thompson received his undergraduate degree in Physiology from the University of California, Davis and his MD from the University of California, Davis Medical School. He completed an internal medicine residency and chief medical residency at the New England Deaconess Hospital and his pulmonary and critical care fellowship at the Massachusetts General Hospital where he subsequently joined the Staff.


Boyd Taylor Thompson, ...

www.frontieratx.com [cached]

Boyd Taylor Thompson, M.D.

Professor of Medicine at Harvard Medical School, Director of Medical ICU at Massachusetts General Hospital
Counsel


The findings of the cancelled study ...

www.adamsmd.com [cached]

The findings of the cancelled study may be sufficient to change treatment of patients with ARDS, Dr. B. Taylor Thompson, of Massachusetts General Hospital and Harvard Medical School, wrote in an accompanying editorial.

"[Beta-2] agonist treatment in patients with ARDS should be limited to the treatment of clinically important reversible airway obstruction and should not be part of routine care," Thompson recommended.


The Wellman Center for Photomedicine: Faculty Laboratories

www2.massgeneral.org [cached]

Brian Thompson, PhD Research Technologist

Similar Profiles

Other People with this Name

Other people with the name Thompson

Jon Thompson
Ripon Farm Services Ltd

Corby Thompson
Hamilton County Economic Development Corporation

Neil Thompson
Acklam Whin Primary

Shannon Thompson
Richmond Hill Toyota

Interim Thompson
HVABSA League Calendar

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory